Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and Vomiting
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
Recent evidence suggests multiple drug therapy is superior to single agents. The study
compares the incidence of nausea, vomiting, need for rescue medication, prolonged PACU time,
and unplanned hospital admission in patients with high risk for PONV treated with oral
aprepitant with or without transdermal scopolamine preoperatively.